Skip to content

Clinical trials

Bronchiolitis Obliterans Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Clear all

702 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20021
200311
200411
200516
200620
200723
200827
200925
201034
201131
201237
201333
201428
201543
201635
201725
201825
201925
202028
202125
202225
202329
202448
202554
202635

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed383
Recruiting90
Unknown status79
Terminated67
Active, not recruiting36
Withdrawn22
Not yet recruiting19
Enrolling by invitation4
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals17
Hoffmann-La Roche12
Dana-Farber Cancer Institute11
Fred Hutchinson Cancer Center11
Incyte Corporation11
National Cancer Institute (NCI)10
AstraZeneca9
Pfizer9
Gilead Sciences8
M.D. Anderson Cancer Center7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome702
Pain51
Graft vs Host Disease46
Low Back Pain43
Leukemia41
Hepatitis C22
Lymphoma, Follicular20
Stroke20
Leukemia, Lymphocytic, Chronic, B-Cell19
Bronchiolitis Obliterans18

Trials

Showing 1 to 25 of 702. Each trial links to its page on Pharma Observatory.

602 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.